alzheimers.global-summit.comDementia Conferences 2020 | Alzheimers Disease Conferences | Dementia Congress 2020 | World Dementia

Toggle navigation MENU Home About Us Journals A-Z Journals Browse by Subject Newly Launched Journals Open Access Conferences Upcoming Conferences Previous Conferences Past Conferences Reports Abstract Registration Technical Program Symposium & Contact Details Scientific Program Call for Abstracts Brochure & Contact Details Poster Submission Speaker Guidelines & FAQs Terms & Conditions B2B Venue & Hospitality Sponsors / Exhibitors Sponsors Exhibition Our Supporters 2018 Supporters 2017 Supporters 2016 Supporters 2015 Supporters 2014 Supporters 2013 Supporters 2012 Supporters 2011 Supporters Awards Research Excellence Awards Poster Presentation Young Researchers Forum ePoster Presentation 15 th World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness November 30-December 01, 2020 Barcelona, Spain Submit Abstract Register Now Sessions & Tracks Program Schedule Reader Base Awards 2020 Market Analysis Search 1000+ Events Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business. Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer Conference Series LLC Ltd Conferences gaining more Readers and Visitors Conference Series LLC Ltd Web Metrics at a Glance 3000+ Global Events 100 Million+ Visitors 75000+ Unique visitors per conference 100000+ Page views for every individual conference Unique Opportunity! Online visibility to the Speakers and Experts Recommended Global Neuroscience Conferences Europe & UK Neuroscience 2020 , Italy Psychology 2020 , UK Addiction Congress 2020 , Italy Asia Pacific & Middle East Neuro Oncology 2020 , Australia Addiction Therapy Meet 2020 , Indonesia Neuro-Science-2020 , Hungary Neurochemistry 2020 , Australia Canada Psychiatric Nursing 2020 , Canada Neurologists Conference 2020 , Canada Psych Central 2020 , Canada Alzheimer’s 2020 About Conference Market Analysis Past Conference Report About Conference We Welcome you for 15th World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness on November 30-December 01, 2020- Barcelona, Spain The Alzheimer’s disease is currently ranked as the sixth leading cause of death in the United States, but recent estimates indicate that the disorder may rank third, just behind heart disease and cancer, as a cause of death for older people. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities. Dementia ranges in severity from the mildest stage, when it is just beginning to affect a person’s functioning, to the most severe stage, when the person must depend completely on others for basic activities of daily living. The causes of dementia can vary, depending on the types of brain changes that may be taking place. Other dementias include Lewy body dementia , frontotemporal disorders , and vascular dementia . It is common for people to have mixed dementia —a combination of two or more types of dementia. For example, some people have both Alzheimer’s disease and vascular dementia. Alzheimer’s disease is named after Dr. Alois Alzheimer. In 1906, Dr. Alzheimer noticed changes in the brain tissue of a woman who had died of an unusual mental illness. Her symptoms included memory loss, language problems, and unpredictable behavior. After she died, he examined her brain and found many abnormal clumps (now called amyloid plaques) and tangled bundles of fibers (now called neurofibrillary, or tau, tangles). These plaques and tangles in the brain are still considered some of the main features of Alzheimer’s disease. Another feature is the loss of connections between nerve cells (neurons) in the brain. Neurons transmit messages between different parts of the brain, and from the brain to muscles and organs in the body. Young Scientist Benefits: Our conferences provide best Platform for your research through oral presentations. Share the ideas with both eminent researchers and mentors. Young Scientist Award reorganization certificate and memento to the winners Young Scientists will get appropriate and timely information by this Forum. Platform for collaboration among young researchers for better development Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole. Deadline for Registrations: Till December 30, 2019 – $399 Till January 30, 2020 – $449 Till February 28, 2020 – $499 Changes in the Brain Scientists continue to unravel the complex brain changes involved in the onset and progression of Alzheimer’s disease. It seems likely that changes in the brain may begin a decade or more before memory and other cognitive problems appear. During this preclinical stage of Alzheimer’s disease, people seem to be symptom-free, but toxic changes are taking place in the brain. Abnormal deposits of proteins form amyloid plaques and tau tangles throughout the brain. Once-healthy neurons stop functioning, lose connections with other neurons, and die. Many other complex brain changes are thought to play a role in Alzheimer’s, too. The damage initially appears to take place in the hippocampus and the entorhinal cortex, parts of the brain essential in forming memories. As more neurons die, additional parts of the brain are affected and begin to shrink. By the final stage of Alzheimer’s, damage is widespread, and brain tissue has shrunk significantly. Signs and Symptoms Memory problems are typically one of the first signs of cognitive impairment related to Alzheimer’s disease. Some people with memory problems have a condition called mild cognitive impairment (MCI). In MCI, people have more memory problems than normal for their age, but their symptoms do not interfere with their everyday lives. Movement difficulties and problems with the sense of smell have also been linked to MCI. Older people with MCI are at greater risk for developing Alzheimer’s, but not all of them do. Some may even go back to normal cognition. The first symptoms of Alzheimer’s vary from person to person. For many, decline in non-memory aspects of cognition, such as word-finding, vision/spatial issues, and impaired reasoning or judgment, may signal the very early stages of Alzheimer’s disease. Researchers are studying biomarkers (biological signs of disease found in brain images, cerebrospinal fluid, and blood) to detect early changes in the brains of people with MCI and in cognitively normal people who may be at greater risk for Alzheimer’s. Studies indicate that such early detection is possible, but more research is needed before these techniques can be used routinely to diagnose Alzheimer’s disease in everyday medical practice. Mild Alzheimer’s Disease As Alzheimer’s disease progresses, people experience greater memory loss and other cognitive difficulties. Problems can include wandering and getting lost, trouble handling money and paying bills , repeating questions, taking longer to complete normal daily tasks, and personality and behavior changes . People are often diagnosed in this stage. Moderate Alzheimer’s Disease In this stage, damage occurs in areas of the brain that control language, reasoning, sensory processing, and conscious thought. Memory loss and confusion grow worse, and people begin to have problems recognizing family and friends. They may be unable to learn new things, carry out multistep tasks such as getting dressed, or cope with new situations. In addition, people at this stage may have hallucinations, delusions, and paranoia and may behave impulsively. Severe Alzheimer’s Disease Ultimately, plaques and tangles spread throughout the brain, and brain tissue shrinks significantly. People with severe Alzheimer’s cannot communicate and ar...